23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research

23andMe Research Institute and Scripps Research have partnered to use genetic data to recruit participants for a new Alzheimer's prevention study called the Wellderly Brain Study. The trial aims to test whether digital lifestyle coaching can impact biological markers associated with Alzheimer's disease.
Why it matters
This partnership leverages large-scale genetic databases to advance precision medicine and preventative strategies for neurodegenerative diseases.
Partnership pairs 23andMe Research Institute's consented research community with novel Scripps Research-led Alzheimer's prevention study
PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute and Scripps Research, through its operating division the Scripps Research Translational Institute (SRTI), are partnering to bring genetics-based recruitment to Alzheimer's disease research. Under the partnership, 23andMe Research Institute will serve as the recruitment partner for the Wellderly Brain Study, which aims to determine whether lifestyle modification can shift disease-related biological pathways, providing a scalable, evidence-based model for early Alzheimer's prevention and monitoring.
"We’re thrilled to partner with the 23andMe Research Institute who are providing invaluable support to identify suitable participants,” said Eric Topol, M.D., Executive Vice-President of Scripps Research. "Our aspiration, which we believe will ultimately be achievable, is to prevent Alzheimer’s disease.”
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in